mercaptoacetyltriglycine

mercaptoacetyltriglycine

An imaging agent (99mTc-mercaptoacetyltriglycine) which has been used in preoperative renal scintigraphy to predict post-nephrectomy chronic renal insufficiency. The technique was reported to be inferior to preoperative estimated glomerular filtration rate (eGFR) in predicting the development of advanced-stage chronic kidney disease after unilateral nephrectomy.
Mentioned in ?
References in periodicals archive ?
The mercaptoacetyltriglycine (MAG-III) renal scan showed right-side obstruction with a split function of 41.
Scintigraphy, using either diethylenetriamine pentaacetic acid labeled with technetium 99m (DTPA) or mercaptoacetyltriglycine marked with technetium 99m (MAG3) (diuretic renogram), is used when obstruction is the suspected cause of a dilated renal pelvis; in addition, this technique calculates the differential renal function (11, 16).
Comparison of differential renal function using technetium-99m mercaptoacetyltriglycine (MAG3) and technetium-99m dimercaptosuccinic acid (DMSA) renography in a paediatric population.
Tc-99m mercaptoacetyltriglycine (MAG3) is the most popular radiotracer used for this purpose.
Mercaptoacetyltriglycine - MAG3 Uses diuretic to evaluate suspected urinary tract obstruction.
6] Renal scarring may be assessed with either dimercaptosuccinic acid (DMSA) or mercaptoacetyltriglycine (MAG3) renal scans.